mcl-1 inhibitor compounds and their use in antibody-drug conjugates.
CL202601585A1Pending Publication Date: 2026-08-21GENENTECH INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202601585
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-14
- Filing Date
- 2026-05-13
- Publication Date
- 2026-08-21
Abstract
This document describes compounds of formula (I) and pharmaceutically acceptable salts thereof. It also describes antibody-drug conjugates (ADCs) comprising a compound of formula (I), or a pharmaceutically acceptable salt thereof, as a payload. Methods for treating disorders are also described.
Need to check novelty before this filing date? Find Prior Art